{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T19:45:18Z","timestamp":1775677518128,"version":"3.50.1"},"reference-count":13,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2015,4,20]]},"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:p>While the medical abortion (MA) drugs, mifepristone and misoprostol, have radically altered reproductive health practices around the world, there has been little field research on the sales and use of these drugs, especially in developing countries. This leaves the family planning community with many unanswered questions. While good profiles of contraceptive use are available for many countries and we have good technical data on the MA drugs\u2019 efficacy, dosages and regimens such as home dosage of misoprostol versus clinic dosage, we have very little information about the quantities of MA drugs sold, how they are used, where they are used, and, in the case of misoprostol, for what purposes. Sales data are available from one excellent commercial survey and from social marketing sales of mifepristone and misoprostol and these are presented. Acknowledging the sensitivity of the issue, especially in countries where abortion is severely restricted, the author makes a plea for careful additional research to shed light on an important and growing part of the international reproductive health picture.<\/jats:p>","DOI":"10.1136\/jfprhc-2014-100990","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T01:59:45Z","timestamp":1435024785000},"page":"193-196","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Medical abortion: the hidden revolution"],"prefix":"10.1136","volume":"41","author":[{"given":"Phil","family":"Harvey","sequence":"first","affiliation":[{"name":"Chairman, DKT International, Washington DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"key":"2025090513150610000_41.3.193.1","first-page":"26","article-title":"Medical abortion: a fact sheet","volume-title":"Reprod Health Matters","volume":"13","author":"Berer","year":"2005"},{"key":"2025090513150610000_41.3.193.2","unstructured":"The ICMA Information Package on Medical Abortion. http:\/\/www.medicalabortionsoncortium.org\/articles\/for-women\/main book\/?bl=en and at http:\/\/misoprostol.org\/ [accessed 26 March 2015]."},{"key":"2025090513150610000_41.3.193.3","unstructured":"Gynuity Health Projects. http:\/\/gynuity.org [accessed 26 March 2015]."},{"key":"2025090513150610000_41.3.193.4","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/S0140-6736(05)66593-2","article-title":"Abortion drugs must become WHO essential medicines","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"2025090513150610000_41.3.193.5","unstructured":"World Health Organization. Safe Abortion: Technical and Policy Guidance for Health Systems (2nd edn). 2013. http:\/\/www.who.int\/reproductivehealth\/publications\/unsafe_abortion\/9789241548434\/en\/ [accessed 26 March 2015]."},{"key":"2025090513150610000_41.3.193.6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0968-8080(05)26204-3","article-title":"Medical abortion: issues of choice and acceptability","volume":"13","author":"Berer","year":"2005","journal-title":"Reprod Health Matters"},{"key":"2025090513150610000_41.3.193.7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2006.02.012","article-title":"Women's perceptions on medical abortion","volume":"74","author":"Ho","year":"2006","journal-title":"Contraception"},{"key":"2025090513150610000_41.3.193.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2008.12.016"},{"key":"2025090513150610000_41.3.193.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61786-8"},{"key":"2025090513150610000_41.3.193.10","unstructured":"DKT International. Contraceptive Social Marketing Statistics (annual data)."},{"key":"2025090513150610000_41.3.193.11","unstructured":"Chhabra R , Nuna SC . Abortion in India: An Overview. 1994. http:\/\/www.cehat.org\/publications\/PDF%20files\/r24.pdf [accessed 26 March 2015]."},{"key":"2025090513150610000_41.3.193.12","unstructured":"Mittal S , Aggarwal P . Interventions for Emergency Contraception: RHL Commentary (last revised: 1 November 2012). The WHO Reproductive Health Library . Geneva, Switzerland: World Health Organization , 2012."},{"key":"2025090513150610000_41.3.193.13","unstructured":"Television advertisement for medical abortion pills from DKT India \u2018A Doctor Tells a Doctor\u2019. http:\/\/www.youtube.com\/watch?v=wEzW8ijXeCw [accessed 26 March 2015]."}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jfprhc-2014-100990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T20:15:16Z","timestamp":1757103316000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/jfprhc-2014-100990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,22]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,6,22]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1136\/jfprhc-2014-100990"],"URL":"https:\/\/doi.org\/10.1136\/jfprhc-2014-100990","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"value":"1471-1893","type":"print"},{"value":"2045-2098","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,22]]}}}